Prevymis (letermovir) - Merck (MSD)
Real-world outcomes of letermovir use in pediatric hematopoietic stem cell transplant recipients (ASHP 2025) - Dec 14, 2025 - Abstract #8-126; Pres time: Dec 9, 2025; 02:00 PM - 03:30 PM; Location: MB South, MB South, Bayside A, Level 1; No abstract available 
Clinical • Real-world • Real-world evidence • Bone Marrow Transplantation • Pediatrics • Transplantation
https://midyear2025.eventscribe.net/fsPopup.asp?PosterID=775047&mode=posterInfo
 
Ana María Agüí Callejas, n/a; Carmen Redondo Galán; Cecilia Martínez Fernández-Llamazares; Ana Herranz Alonso; María Sanjurjo Saez
 
Dec 14, 2025
 
Prev Next